PARP1 is significantly amplified and highly expressed in recurrent breast cancer, while PTEN loss has been linked to an increased risk of breast cancer, and AIFM1 plays a crucial role in tumor invasion and metastasis by inactivating PTEN [10,11]. Here, PTEN is linked to breast carcinoma.